Position in BDTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,457,809
+$667,266 QoQ
Shares Held
684,418
+110.4% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. BDTX ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in BDTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,457,809 | 684,418 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $790,543 | 325,327 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,701,777 | 449,018 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $869,596 | 350,644 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $743,049 | 479,387 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,035,409 | 483,836 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,222,419 | 281,016 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $294,138 | 63,120 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,689,567 | 333,248 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $129,217 | 45,985 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $69,323 | 36,679 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $66,610 | 37,006 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $92,912 | 54,978 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $251,229 | 102,126 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $501,638 | 181,097 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $704,391 | 132,156 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,066,856 | 126,106 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,358,301 | 193,462 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,050,648 | 84,528 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,315,804 | 72,256 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $237,970 | 7,872 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $717,436 | 17,017 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,246,423 | 90,037 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||